News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

New Nanoparticles Clean the Environment, Drinking Water

September 18, 2015 8:45 am | by Bevin Fletcher, Associate Editor | Articles | Comments

Nanoparticles are between 1 and 100 nanometers in size.Scientists can harness them for drug delivery, to combat disease, for filtering fresh drinking water, and much more. Now, researchers from MIT and the Federal University of Goias in Brazil have developed a new technique that uses ultraviolet (UV) light to extract man-made pollutants from soil and water.


FDA Accepts NDA for First-Ever Digital Medication

September 18, 2015 8:00 am | by Ryan Bushey, Associate Editor | News | Comments

An ingestible sensor is built into the tablet.


Rabbit Monoclonal Antibody to Group A Strep

September 17, 2015 10:29 am | Virostat, Inc. | Product Releases | Comments

ViroStat has released a new Rabbit Monoclonal Antibody to the GAC of group A Strep. This antibody functions in ELISA and lateral flow immunoassay applications. It pairs with itself as well as with the existing ViroStat OMNITOPE polyclonal antibodies (goat & rabbit).


Nanoparticles Can Make Medicines More Effective

September 17, 2015 10:24 am | by UC San Diego | News | Comments

Nanoparticles disguised as human platelets could greatly enhance the healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These platelet-mimicking nanoparticles are capable of delivering drugs to targeted sites in the body — particularly injured blood vessels, as well as organs infected by harmful bacteria.


Study: Air Pollution Kills 3.3 Million Worldwide, May Double

September 17, 2015 9:42 am | by Seth Borenstein, AP Science Writer | News | Comments

Air pollution is killing 3.3 million people a year worldwide, according to a new study that includes this surprise: Farming plays a large role in smog and soot deaths in industrial nations.


Alzheimer’s Disease Consists of Three Distinct Subtypes, Study Says

September 17, 2015 8:39 am | by UCLA | News | Comments

Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes, according to a recent study. The finding could lead to more highly targeted research and, eventually, new treatments for the debilitating neurological disorder, which robs people of their memories.


‘Achilles’ Heel’ of Sickle Cell Disease?

September 17, 2015 8:38 am | by Harvard University | News | Comments

Researchers have found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease. The discovery, outlined in the journal Nature, opens a promising path for developing gene-editing approaches to treat the disease and other hemoglobin disorders.


Beet Juice Boosts Muscle Power in Heart Patients

September 17, 2015 8:37 am | by Washington University in St. Louis | News | Comments

Scientists have evidence that Popeye was right: Spinach makes you stronger. But it’s the high nitrate content in the leafy greens — not the iron — that creates the effect. Building on a growing body of work that suggests dietary nitrate improves muscle performance in many elite athletes, researchers  found that drinking concentrated beet juice — also high in nitrates — increases muscle power in patients with heart failure.


Excess Weight Tied to Increased Risk of Brain Tumor Type

September 17, 2015 8:36 am | by Bevin Fletcher, Associate Editor | News | Comments

There may be a link between being overweight or obese and an increased risk of a specific type of brain tumor, according to a new meta-analysis published online Sept. 16 in Neurology.


Three “Remarkable” Studies Say Clogged Pores May Cause ALS; Drug Targets ID’d

September 17, 2015 8:35 am | by Cynthia Fox, Science Writer | Articles | Comments

Three studies, analyzing in different ways the leading ALS gene, came to what is being called a “remarkably” similar conclusion: the most common form of ALS may be caused by clogged pores in brain cell nuclear membranes.


Pharmaceutical Raw Materials

September 16, 2015 9:19 am | EMD Millipore | Product Releases | Comments

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, introduced enhancements to its industry-leading EMPROVE portfolio of pharmaceutical raw materials. The expanded documentation and regulatory information facilitates drug product manufacturers’ risk assessment workflows and supplier qualification.

Genetic Sleuthing

September 16, 2015 9:02 am | by Harvard University | News | Comments

Scientists fighting last year’s outbreak of Ebola used the power of genetic sequencing to unlock the secrets of the deadly virus, and now they’re doing the same for a similar, and far more prevalent, disease — Lassa fever.


Sewage Study Helps to Understand Human Health

September 16, 2015 8:48 am | by Julia Sklar, MIT News correspondent | News | Comments

Although sewage is something most people prefer to leave out of sight and out of mind, it can be a gold mine of information. A small sample of sewage is likely to contain a variety of biomarkers that can yield data on infectious and chronic diseases such as influenza and inflammatory bowel disease (IBD).


'Our Chairs Are Killing Us,' Say Researchers

September 16, 2015 8:47 am | by Elsevier Health Sciences | News | Comments

Prolonged sitting time as well as reduced physical activity contribute to the prevalence of non-alcoholic fatty liver disease (NAFLD) in a study of middle-aged Koreans. These findings support the importance of both reducing time spent sitting and increasing physical activity, say researchers.


Potential New Biomarker for Migraines

September 16, 2015 8:45 am | by Bevin Fletcher, Associate Editor | News | Comments

Researchers at the Johns Hopkins University School of Medicine may have found a new blood biomarker for episodic migraines, according to recent research. 



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.